Story

    Russia's AI-Assisted Cancer Vaccine, Targeting Melanoma, Set for Approval in August and Treatments in September 2025

    Russia's AI-Assisted Cancer Vaccine, Targeting Melanoma, Set for Approval in August and Treatments in September 2025

    5 postsRussiaHealthAI ModelingWorldScienceAI

    Russia is set to begin treatments using a groundbreaking AI-assisted cancer vaccine by September 2025, according to the Ministry of Health. The personalized vaccine, designed to target melanoma and assist post-treatment patients, can be created within a week for individual patients. Alexander Gintsburg, director of the Gamaleya Center, confirmed that the vaccine is expected to receive approval in August 2025. The use of artificial intelligence will facilitate the analysis of tumor parameters, allowing specialists to tailor the vaccine specifically to each patient's needs.

    Related Market Proposals

    Related Polymarket Markets